Standing Alone While Standing Together: A Conversation With Millennium CEO Dunsire (Pt. 2 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Dunsire talks about what it takes for Millennium, Takeda's Oncology program, to operate a a stand-alone unit within the Japanese pharma, and strategies to retain key staff and culture.